» Articles » PMID: 36355554

Modulation of Cytoskeleton, Protein Trafficking, and Signaling Pathways by Metabolites from , and Plant Families

Abstract

One promising frontier within the field of Medical Botany is the study of the bioactivity of plant metabolites on human health. Although plant metabolites are metabolic byproducts that commonly regulate ecological interactions and biochemical processes in plant species, such metabolites also elicit profound effects on the cellular processes of human and other mammalian cells. In this regard, due to their potential as therapeutic agents for a variety of human diseases and induction of toxic cellular responses, further research advances are direly needed to fully understand the molecular mechanisms induced by these agents. Herein, we focus our investigation on metabolites from the and plant families, for which several plant species are found within the state of Florida in Hillsborough County. Specifically, we compare the molecular mechanisms by which metabolites and/or plant extracts from these plant families modulate the cytoskeleton, protein trafficking, and cell signaling to mediate functional outcomes, as well as a discussion of current gaps in knowledge. Our efforts to lay the molecular groundwork in this broad manner hold promise in supporting future research efforts in pharmacology and drug discovery.

Citing Articles

Deep-Sea Sponges and Corals off the Western Coast of Florida-Intracellular Mechanisms of Action of Bioactive Compounds and Technological Advances Supporting the Drug Discovery Pipeline.

Iskandar M, Ruiz-Houston K, Bracco S, Sharkasi S, Calabi Villarroel C, Desai M Mar Drugs. 2023; 21(12).

PMID: 38132936 PMC: 10744787. DOI: 10.3390/md21120615.

References
1.
Yu M, Im H, Lee S, Kim D, Seo H, Lee I . Inhibitory effect of immature plum on PMA-induced MMP-9 expression in human hepatocellular carcinoma. Nat Prod Res. 2009; 23(8):704-18. DOI: 10.1080/14786410802263485. View

2.
Boykin C, Zhang G, Chen Y, Zhang R, Fan X, Yang W . Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation. Br J Cancer. 2011; 104(5):781-9. PMC: 3048206. DOI: 10.1038/bjc.2011.10. View

3.
Dakeng S, Duangmano S, Jiratchariyakul W, U-Pratya Y, Bogler O, Patmasiriwat P . Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus. J Cell Biochem. 2011; 113(1):49-60. PMC: 3245346. DOI: 10.1002/jcb.23326. View

4.
Zhang L, Liang H, Xin Y . Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway. Anticancer Drugs. 2020; 31(8):847-855. DOI: 10.1097/CAD.0000000000000961. View

5.
Liu P, Xiang Y, Liu X, Zhang T, Yang R, Chen S . Cucurbitacin B Induces the Lysosomal Degradation of EGFR and Suppresses the CIP2A/PP2A/Akt Signaling Axis in Gefitinib-Resistant Non-Small Cell Lung Cancer. Molecules. 2019; 24(3). PMC: 6384961. DOI: 10.3390/molecules24030647. View